Status:
COMPLETED
Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Non-Hodgkin Lymphoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the ability of pegfilgrastim vs. filgrastim to mobilize peripheral blood stem cells in patients with Non Hodgkin-lymphoma in an intraindividual study
Detailed Description
Patients with Non Hodgkin-lymphoma undergoing stem cell mobilization for planned high-dose therapy will be treated with two cycles of chemotherapy (etoposide, ifosfamide, cisplatin, epirubicin), eithe...
Eligibility Criteria
Inclusion
- histological diagnosis of non-Hodgkin lymphoma
- planned high-dose therapy with autologous stem cell transplantation
- WHO performance status 0-2
- written consent
Exclusion
- allergy against (peg)filgrastim
- life expectancy \<3 months
- other malignant diseases within the last 5 years
- cardial insufficiency (\>= New York Heart Association II°)
- uncontrolled infection
- pregnancy, lactation
- central nervous system lymphoma
- Karnofsky score \<70%
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00306111
Start Date
January 1 2006
End Date
December 1 2011
Last Update
May 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Medicine 2, University of Tuebingen
Tübingen, Baden-Wurttemberg, Germany, 72076